OMG Special Interest Group for Life Sciences Research

Timothy Slidel slidel at
Wed Aug 20 17:16:43 EST 1997

Please note,

If you would like to subscribe to the Life Sciences Research DSIG
mailing list (as discussed below) you should send an email to
request at to that effect (do NOT send directly to
lifesciences at Your email will be read and acted upon by a
human being rather than an automated list manager.

Many thanks,

Tim Slidel

W. David Benton writes:
 > Report: Life Sciences Research Domain Special Interest Group Organizational 
 > Meeting
 > Representatives of biotechnology software vendors, pharmaceuticals and 
 > biotechnology companies, and academia interested in promoting component-based 
 > software development in life sciences research met in Philadelphia on 5 and 6 
 > August 1997.  Graham Cameron (EBI) chaired the meeting and Tim Clark (Millenium 
 > Pharmaceuticals) was the recorder.  The attendees (see list below) voted to 
 > apply to the Object Management Group (OMG) for recognition as a Domain Special 
 > Interest Group (DSIG) for Life Sciences Research at the next regular OMG 
 > meeting, to be held in Dublin, Ireland, 22-26 September 1997.  The attendees 
 > also developed and approved the attached statements of mission and goals for 
 > the DSIG and elected as acting DSIG co-chairs: David Benton (SmithKline Beecham
 > , W_David_Benton at, Nat Goodman (Jackson Laboratory, nat at, 
 > Eric Neumann (NetGenics, eneumann at, and Tim Slidel (European 
 > Bioinformatics Institute, slidel at
 > The Life Sciences Research DSIG plans to hold its first meeting on 22-24 
 > September in conjunction with the OMG meeting at the Davenport Hotel, Dublin.  
 > This meeting is open to all interested members of the life sciences research 
 > software and database community, whether or not they are currently members of 
 > the OMG.  The principal agenda items for the September meeting are: 1) 
 > establishing any necessary bylaws for the SIG, 2) determining a schedule of 
 > future meetings (see below for the schedule of future OMG meetings) and 3) 
 > developing first drafts of a Request for Information (RFI) and a Technology 
 > Roadmap for the SIG.  An RFI is a general request to industry, academia, and 
 > any other interested parties to submit information about a particular 
 > technology area to one of the OMG Task Forces.  The responses to an RFI provide 
 > information required for developing a Technology Roadmap or timetable for 
 > issuance of RFPs or additional RFIs. A Request For Proposal (RFP) is an 
 > explicit request to OMG members to submit proposals for technology evaluation 
 > and technology adoption.  Prior to the September meeting, Nat Goodman will 
 > prepare a strawman RFI and Roadmap.  Comments for inclusion in these documents 
 > should be send directly to Dr. Goodman (nat at
 > For more information about the Object Management Group, CORBA, the OMG 
 > technology adoption process, and the registering for the September OMG meeting, 
 > see  To receive announcments about Life Sciences Research 
 > DSIG activities, subscribe to the SIG's mailing list: lifesciences at
 > ====================================================
 > Life Sciences Research DSIG Mission:
 > * To improve the quality and utility of software and information systems used 
 > in Life Sciences Research through use of interoperable distributed object 
 > technology.
 > * To encourage the development of interoperable software tools and services in 
 > Life Sciences Research.
 > * To use the Object Management Group (OMG) technology adoption process to 
 > standardize interfaces for software tools, services, frameworks, and components 
 > in Life Sciences Research.
 > * To communicate the requirements of the Life Sciences Research domain to the 
 > Platform Technical Committee.
 > * To coordinate with OMG Task Forces and Special Interest Groups, and other 
 > standards organizations and information providers to ensure common standards.
 > ----------------------------------------------
 > Life Sciences Research DSIG Goals:
 > * To become a DTF at the December 1997 OMG meeting.
 > * To develop a proposed Request for Information (RFI) and technology road map 
 > by the December 1997 OMG meeting.
 > * To recruit additional members from the broader Life Sciences Research 
 > community.
 > * To issue RFIs and Requests for Proposal (RFPs) related to Life Sciences 
 > Research software and information systems based on CORBA technology.
 > * To evaluate RFI and RFP responses and Requests for Comments (RFCs), for 
 > recommended adoption by the Domain Technical Committee.
 > * To provide a forum for exchange of experiences in the use of the standards 
 > developed.
 > ==============================================================
 > Future OMG Meeting Schedule:
 > December 1-5, 1997 East Brunswick, NJ, USA (Hosted by NEC) 
 > February 9 -13, 1998 Salt Lake City, UT, USA (Hosted by Novell, Inc.) 
 > April 1998**  Location TBD, UK (co-hosted by CAI/ICL) 
 > June 1998   Orlando, FL, USA (hosted by OMG) 
 > late July/August 1998 Helsinki, Finland (hosted by Nokia) 
 > October 1998  Seattle, WA, USA (hosted by Boeing) 
 > December 1998  San Francisco, CA, USA (hosted by Oracle) 
 > **Tentative
 > =====================================================
 > Life Sciences Research DSIG Organizational Meeting Attendees:
 > David Benton SmithKline Beecham  W_David_Benton at
 > Howard Bilofsky SmithKline Beecham  Howard_S_Bilofsky at
 > Joe Brown  MDL Info Systems   JoeB at
 > Dave Callendar NetGenics    dcallendar at
 > Graham Cameron EBI     cameron at
 > Tim Clark  Millenium Pharma   clark at
 > Mark Cortelyou Oxford Molecular Group  MCortelyou at
 > Sid Cowles  Incyte    scowles at
 > Scott Dixon  SmithKline Beecham  J_Scott_Dixon at
 > Rainer Fuchs Glaxo Wellcome   rf11522 at
 > David George Bristol-Myers Squibb  georged at
 > Richard Giaimo MSI     rgiaimo at
 > Nat Goodman  Jackson Labs   nat at
 > Hsi-Chen Han Wyeth-Ayerst Research  hanh at
 > Kyle Hart  Pangea Systems   kylehart at
 > Sunny Hung  SmithKline Beecham  Sunny_T_Hung at
 > Kathy Kelley SmithKline Beecham  Katherine_G_Kelley at
 > Karl Konnerth Incyte    kkonnerth at
 > Charlie Lawrence Sequana Therapeutics  chas at
 > Michael Liebman Wyeth Ayerst Research  mliebman at
 > Mark Lowenstein Object Management Group  mark at
 > Sherri Matis Zeneca Pharmaceuticals  Sherri.matis at
 > Dave McAllister Silicon Graphics   davemc at
 > Jeff McDowell Abbott Labs    jeffrey.McDowell at
 > Mitchell Model Millenium Pharmaceuticals model at
 > Brian Moldover Parke-Davis Pharma  moldovb at
 > Juli Nash  Silicon Graphics   nash at
 > Eric Neumann NetGenics    eneumann at
 > Jeri Okamura Genome Therapeutics  jeri.okamura at
 > Mike Olson  Molecular Applications Group mao at
 > Jim Ostell  NCBI, NIH    ostell at
 > Chris Overton U. Penn.    coverton at
 > Sejal Patel  RW Johnson Pharma RI  spatel at
 > Michael Pear Molecular Simulations  mpear at
 > Randy Premont Resource 2000   rpremont at
 > Tana Reagan  Concept Five Techn  reagan at
 > Kerry Reinertsen Millenium Pharma   reinertsen at
 > John Sadler  Hewlett-Packard Bioscience John_Sadler at
 > David Samuel Compugen    david at
 > Martin Schray NetGenics    mschray at
 > Mike Sievers Paracel    sievers at
 > Steve Smith  GCG/OMG    Steve.Smith at
 > Jay Snoddy  Oak Ridge Nat'l Lab  SnoddyJ at
 > Geoff Speare OMG     geoff at
 > Lisa Staggenborg Chemical Abstracts Service lstaggenborg at
 > Val Tannen  UPenn Center for Bioinformatics val at
 > Arthur Thomas Proteus Assoc.   ajt at
 > Frank Wang  Proctor & Gamble   wang.ff at
 > Luquan Wang  Schering-Plough Research at
 > Art Williams SmithKline Beecham  Art_Williams at
 > Jeff Wilson  Molecular Informatics  jaw at
 > Merrie Wise  SmithKline Beecham  Merrie_Wise at
 > Peter Woollard MRC Human Genome Mapping Resource P.Woollard at HGMP.MRC.AC.UK

Timothy Slidel (PhD), Industry Support Programme,
European Bioinformatics Institute (EMBL Outstation),
Wellcome Trust Genome Campus
Hinxton, Cambridge CB10 1SD, UK.

E-mail: slidel at
Tel: 44 (0)1223 494651
Fax: 44 (0)1223 494468

More information about the Bionews mailing list